HealthLynked discusses year-end financials and MedOfficeDirect prospects in development | News Direct

HealthLynked discusses year-end financials and MedOfficeDirect prospects in development

News release by HealthLynked

facebook icon linkedin icon twitter icon pinterest icon email icon New York | April 05, 2023 01:13 PM Eastern Daylight Time

HealthLynked chairman and CEO Dr Michael Dent and chief financial officer George O'Leary join Proactive's Natalie Stoberman to share highlights from the company's fourth-quarter and full-year 2022 financial results.

HealthLynked reported revenue of $5.86 million, a 10% decrease compared to $6.50 million in 2021.

Dent says the decline is primarily attributed to decreases in patient service revenue at the Naples Women’s Center and Bridging the Gap facilities, as well as lower product revenue from MedOfficeDirect. However, the company has reported that the decrease was partially offset by revenue increases at its Naples Center for Functional Medicine facility and revenue from the newly-acquired Aesthetics Enhancements Unlimited practice.

 

 

Contact Details

 

Proactive Investors

 

+1 347-449-0879

 

na-editorial@proactiveinvestors.com

Tags

proactiveinvestorshealthlynkedOTCQBHLYKfinancialresultsyearenddigitalhealthcaremedicalinformationmedofficedirectinvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews